GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Total Stockholders Equity

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Total Stockholders Equity : ¥1,389 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Total Stockholders Equity?

Beijing Bohui Innovation Biotechnology Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,389 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Beijing Bohui Innovation Biotechnology Group Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥1.70. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Beijing Bohui Innovation Biotechnology Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.68.


Beijing Bohui Innovation Biotechnology Group Co Total Stockholders Equity Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Total Stockholders Equity Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,031.40 1,299.96 974.75 1,393.33 1,369.54

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,398.19 1,400.73 1,408.90 1,369.54 1,389.29

Beijing Bohui Innovation Biotechnology Group Co  (SZSE:300318) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Beijing Bohui Innovation Biotechnology Group Co's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Beijing Bohui Innovation Biotechnology Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Bohui Innovation Biotechnology Group Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Co Ltd operates in the medical device industry. The company is focusing on the research and development, production, sales and after-sales services of in vitro diagnostic products. The main products of the company include human element detection system, vitamin D test kits and infectious pathogen detection system. The company serves over 3,000 healthcare institutions in 31 provinces and autonomous regions in China.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Headlines

No Headlines